For the Inventor, By the Inventor

Enter inventor name

You-Ping Chan

USPTO Granted Patents = 41 (Patent Applications = 19)

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 11 (Patent Applications = 21)

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 292(Granted Patents)

Location History:

Lyon, FR (1999)
Lyons, FR (1998 - 2012)
Ternay, FR (2012 - 2024)

Company Filing History:

11 out of 7,273

Corning Incorporated

Flamel Technologies

Flamel Ireland Limited

7. 1 out of 135

Ares Trading S.a.

8. 1 out of 832,843

Other

patents

Years Active: 1998-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Injectable Solutions

Amylin Analogues

Basal Insulin

Co-Polyamino Acids

Glucagon Compositions

Polyglutamic Acids

Modified-Release Formulations

Photochromic Compounds

Naphthopyrans

Therapeutic Applications

Hydrophobic Functionalization

Polyelectrolytes

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12186373 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid (2025-01-07),

2. 11883496 - Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals (2024-01-30),

3. 11633460 - Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals (2023-04-25),

4. 11191812 - Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid (2021-12-07),

5. 11173109 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid (2021-11-16),

6. 11129877 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid (2021-09-28),

7. 11065305 - Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action (2021-07-20),

8. 10987426 - Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid (2021-04-27),

9. 10610572 - Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action (2020-04-07),

10. 10052289 - Composition comprising an active agent with low aqueous solubility (2018-08-21),

11. 9272020 - IFN-beta compositions, preparation methods and uses thereof (2016-03-01),

12. 8716217 - Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof (2014-05-06),

13. 8481019 - Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof (2013-07-09),

14. 8236353 - Self-precipitating pharmaceutical formulations for the modified release of an active principle (2012-08-07),

15. 8206744 - Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications (2012-06-26),

Title: You-Ping Chan: Innovator in Injectable Aqueous Solutions

Introduction

You-Ping Chan is a prominent inventor based in Ternay, France, with an impressive tally of 41 patents to his name. His work primarily revolves around the formulation of injectable aqueous solutions that play a crucial role in medical therapies, particularly in the realm of diabetes management.

Latest Patents

Among his latest innovations are patents for compositions in the form of injectable aqueous solutions that include amylin, an amylin agonist receptor, or an amylin analogue combined with a co-polyamino acid. These compositions maintain a pH level ranging from 6.0 to 8.0 and are unique in that they do not include basal insulin with an isoelectric point (pI) between 5.8 and 8.5. Additionally, he has developed injectable solutions that comprise a basal insulin with a pI from 5.8 to 8.5 and a co-polyamino acid that bears carboxylate charges along with hydrophobic radicals. These physically stable compositions are significant advancements in the field of drug delivery systems.

Career Highlights

Throughout his career, You-Ping Chan has made substantial contributions to the pharmaceutical industry. He has worked with notable companies such as Corning Incorporated and Flamel Technologies, where he honed his skills and knowledge in the development of innovative medical solutions.

Collaborations

In his professional journey, You-Ping has collaborated with esteemed colleagues such as Olivier Breyne and Patrick Jean. These collaborations have undoubtedly fostered an environment of creativity and innovation, helping to propel forward the advancements in medical technology that Chan is known for.

Conclusion

You-Ping Chan's dedication to innovation in injectable aqueous solutions has established him as a key figure in the advancement of medical therapies. With numerous patents and collaboration with other talented professionals, his contributions continue to impact the industry positively, paving the way for future advancements in drug formulation and delivery.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…